Hypercholesterolemia and Lipid-Lowering Therapy in Children and Adolescents With Type 1 Diabetes: Do We Implement Current Guidelines?
We found a high prevalence of LDL hypercholesterolemia. The use of LLM was low, despite treatment indication, and treatment targets were mostly not achieved either due to underdosing or nonadherence to LLM. These findings confirm that dyslipidemia remains an underestimated cardiovascular risk factor in pediatric diabetology.
Authors
- Johanna Hammersen (ORCID: https://orcid.org/0000-0001-8821-5775)
- Susanne Bechtold‐Dalla Pozza (ORCID: https://orcid.org/0009-0004-6252-8676)
- Marie-Anne Burckhard
- Reinhard Walter Holl
- Marianne Becker
- Martin Holder
- Jantje Weiskorn
- Elke Müller-Roßberg
- Clemens Kamrath
Institutions
- Centre Hospitalier de Luxembourg (LU)
- University of Luxembourg (LU)
- University Medical Center Freiburg (DE)
- University Hospital of Basel (CH)
- Kinderkrankenhaus auf der Bult (DE)
- Universitätsklinikum Erlangen (DE)
- Olgahospital (DE)
- Klinikum Esslingen (DE)
- University Children’s Hospital Basel (CH)
- Deutsches Diabetes-Zentrum e.V. (DE)
- German Center for Diabetes Research (DE)
- Heinrich Heine University Düsseldorf (DE)
- Ludwig-Maximilians-Universität München (DE)
Publication Details
- Journal
- Diabetes Care
- Published
- 2026-03-17
- DOI
- https://doi.org/10.2337/dc25-2459
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00